Novartis Bioventures Ltd Insider Trading Transactions
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Latest Insider Trading Transactions of Novartis Bioventures Ltd
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 890,476 | 0 | 0 | |
Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 10.00 | 300,000 | 3,000,000 | 2,310,924 | 2 M to 2.3 M (+14.92 %) |
Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 2,010,924 | 0 | 2,010,924 | 0 to 2 M |
Jul 17 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.26 | 3,566 | 50,844 | 4,493,458 | 4.5 M to 4.5 M (-0.08 %) |
Jul 15 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.41 | 27,861 | 401,477 | 4,497,024 | 4.5 M to 4.5 M (-0.62 %) |
Jul 15 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 20,611 | 292,717 | 4,524,885 | 4.5 M to 4.5 M (-0.45 %) |
Jun 18 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.27 | 1,120 | 15,982 | 4,545,496 | 4.5 M to 4.5 M (-0.02 %) |
Jun 16 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 14,777 | 209,833 | 4,546,616 | 4.6 M to 4.5 M (-0.32 %) |
Jun 16 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 5,919 | 84,050 | 4,561,393 | 4.6 M to 4.6 M (-0.13 %) |
Jun 12 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 27,875 | 395,825 | 4,567,312 | 4.6 M to 4.6 M (-0.61 %) |
Mar 20 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.50 | 46,141 | 669,045 | 4,595,187 | 4.6 M to 4.6 M (-0.99 %) |
Mar 20 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.50 | 3,000 | 43,500 | 4,641,328 | 4.6 M to 4.6 M (-0.06 %) |
Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 708,647 | 0 | 0 | |
Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 347,831 | 0 | 0 | |
Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 257,031 | 0 | 0 | |
Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 3,223,174 | 0 | 3,405,764 | 182.6 K to 3.4 M (+1,765.25 %) |
Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 17.00 | 182,590 | 3,104,030 | 182,590 | 0 to 182.6 K |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 3,780 | 4,574 | 2,495,065 | 2.5 M to 2.5 M (-0.15 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 2,056 | 2,467 | 2,498,845 | 2.5 M to 2.5 M (-0.08 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.19 | 10,730 | 12,769 | 2,500,901 | 2.5 M to 2.5 M (-0.43 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.18 | 16,784 | 19,805 | 2,511,631 | 2.5 M to 2.5 M (-0.66 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.17 | 19,550 | 22,874 | 2,528,415 | 2.5 M to 2.5 M (-0.77 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.16 | 10,700 | 12,412 | 2,547,965 | 2.6 M to 2.5 M (-0.42 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.15 | 1,900 | 2,185 | 2,558,665 | 2.6 M to 2.6 M (-0.07 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.14 | 1,300 | 1,482 | 2,560,565 | 2.6 M to 2.6 M (-0.05 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.13 | 2,600 | 2,938 | 2,561,865 | 2.6 M to 2.6 M (-0.10 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.12 | 1,200 | 1,344 | 2,564,465 | 2.6 M to 2.6 M (-0.05 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.11 | 1,800 | 1,998 | 2,565,665 | 2.6 M to 2.6 M (-0.07 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.10 | 400 | 440 | 2,567,465 | 2.6 M to 2.6 M (-0.02 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.09 | 700 | 763 | 2,567,865 | 2.6 M to 2.6 M (-0.03 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.08 | 1,000 | 1,080 | 2,568,565 | 2.6 M to 2.6 M (-0.04 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 700 | 840 | 2,569,565 | 2.6 M to 2.6 M (-0.03 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.18 | 400 | 472 | 2,570,265 | 2.6 M to 2.6 M (-0.02 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.17 | 670 | 784 | 2,570,665 | 2.6 M to 2.6 M (-0.03 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.16 | 1,530 | 1,775 | 2,571,335 | 2.6 M to 2.6 M (-0.06 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.15 | 19,200 | 22,080 | 2,572,865 | 2.6 M to 2.6 M (-0.74 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.14 | 9,005 | 10,266 | 2,592,065 | 2.6 M to 2.6 M (-0.35 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.13 | 5,100 | 5,763 | 2,601,070 | 2.6 M to 2.6 M (-0.20 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.12 | 15,100 | 16,912 | 2,606,170 | 2.6 M to 2.6 M (-0.58 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.12 | 600 | 669 | 2,621,270 | 2.6 M to 2.6 M (-0.02 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.11 | 26,200 | 29,082 | 2,621,870 | 2.6 M to 2.6 M (-0.99 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.10 | 12,000 | 13,200 | 2,648,070 | 2.7 M to 2.6 M (-0.45 %) |
Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.09 | 2,500 | 2,725 | 2,660,070 | 2.7 M to 2.7 M (-0.09 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.22 | 6,510 | 7,942 | 2,662,570 | 2.7 M to 2.7 M (-0.24 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 100 | 121 | 2,669,080 | 2.7 M to 2.7 M (0.00 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 23,800 | 28,798 | 2,669,180 | 2.7 M to 2.7 M (-0.88 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 600 | 723 | 2,692,980 | 2.7 M to 2.7 M (-0.02 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 400 | 481 | 2,693,580 | 2.7 M to 2.7 M (-0.01 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 17,907 | 21,488 | 2,693,980 | 2.7 M to 2.7 M (-0.66 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.19 | 3,883 | 4,621 | 2,711,887 | 2.7 M to 2.7 M (-0.14 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.18 | 14,200 | 16,756 | 2,715,770 | 2.7 M to 2.7 M (-0.52 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.17 | 3,000 | 3,510 | 2,729,970 | 2.7 M to 2.7 M (-0.11 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.16 | 2,100 | 2,436 | 2,732,970 | 2.7 M to 2.7 M (-0.08 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.15 | 300 | 345 | 2,735,070 | 2.7 M to 2.7 M (-0.01 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.30 | 200 | 260 | 2,735,370 | 2.7 M to 2.7 M (-0.01 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.29 | 300 | 387 | 2,735,570 | 2.7 M to 2.7 M (-0.01 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.28 | 900 | 1,152 | 2,735,870 | 2.7 M to 2.7 M (-0.03 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.27 | 5,935 | 7,537 | 2,736,770 | 2.7 M to 2.7 M (-0.22 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.26 | 22,865 | 28,810 | 2,742,705 | 2.8 M to 2.7 M (-0.83 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.25 | 34,200 | 42,750 | 2,765,570 | 2.8 M to 2.8 M (-1.22 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.24 | 4,900 | 6,076 | 2,799,770 | 2.8 M to 2.8 M (-0.17 %) |
Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.23 | 200 | 246 | 2,804,670 | 2.8 M to 2.8 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.50 | 1,000 | 1,500 | 2,804,870 | 2.8 M to 2.8 M (-0.04 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.49 | 100 | 149 | 2,805,870 | 2.8 M to 2.8 M (0.00 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.46 | 4,500 | 6,570 | 2,805,970 | 2.8 M to 2.8 M (-0.16 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.45 | 100 | 145 | 2,810,470 | 2.8 M to 2.8 M (0.00 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.43 | 4,400 | 6,292 | 2,810,570 | 2.8 M to 2.8 M (-0.16 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.42 | 2,800 | 3,976 | 2,814,970 | 2.8 M to 2.8 M (-0.10 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.41 | 1,500 | 2,115 | 2,817,770 | 2.8 M to 2.8 M (-0.05 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.40 | 5,200 | 7,280 | 2,819,270 | 2.8 M to 2.8 M (-0.18 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.39 | 4,500 | 6,255 | 2,824,470 | 2.8 M to 2.8 M (-0.16 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.38 | 6,292 | 8,683 | 2,828,970 | 2.8 M to 2.8 M (-0.22 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.37 | 208 | 285 | 2,835,262 | 2.8 M to 2.8 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.35 | 2,700 | 3,645 | 2,835,470 | 2.8 M to 2.8 M (-0.10 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.33 | 2,057 | 2,736 | 2,838,170 | 2.8 M to 2.8 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.32 | 1,943 | 2,565 | 2,840,227 | 2.8 M to 2.8 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.31 | 2,500 | 3,275 | 2,842,170 | 2.8 M to 2.8 M (-0.09 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.30 | 2,000 | 2,600 | 2,844,670 | 2.8 M to 2.8 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.29 | 200 | 258 | 2,846,670 | 2.8 M to 2.8 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.27 | 1,000 | 1,270 | 2,846,870 | 2.8 M to 2.8 M (-0.04 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.26 | 2,700 | 3,402 | 2,847,870 | 2.9 M to 2.8 M (-0.09 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.25 | 2,100 | 2,625 | 2,850,570 | 2.9 M to 2.9 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.24 | 1,800 | 2,232 | 2,852,670 | 2.9 M to 2.9 M (-0.06 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.23 | 800 | 984 | 2,854,470 | 2.9 M to 2.9 M (-0.03 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.22 | 1,000 | 1,220 | 2,855,270 | 2.9 M to 2.9 M (-0.04 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.59 | 100 | 159 | 2,856,270 | 2.9 M to 2.9 M (0.00 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.58 | 700 | 1,106 | 2,856,370 | 2.9 M to 2.9 M (-0.02 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.56 | 8,600 | 13,416 | 2,857,070 | 2.9 M to 2.9 M (-0.30 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.55 | 400 | 620 | 2,865,670 | 2.9 M to 2.9 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.54 | 8,400 | 12,936 | 2,866,070 | 2.9 M to 2.9 M (-0.29 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.53 | 3,300 | 5,049 | 2,874,470 | 2.9 M to 2.9 M (-0.11 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.53 | 500 | 763 | 2,877,770 | 2.9 M to 2.9 M (-0.02 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.52 | 600 | 914 | 2,878,270 | 2.9 M to 2.9 M (-0.02 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.52 | 6,400 | 9,728 | 2,878,870 | 2.9 M to 2.9 M (-0.22 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.51 | 2,900 | 4,379 | 2,885,270 | 2.9 M to 2.9 M (-0.10 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.50 | 10,900 | 16,350 | 2,888,170 | 2.9 M to 2.9 M (-0.38 %) |